CAELIA Health

About CAELIA Health

CAELIA Health is a deep-tech medtech venture in formation from Munich. The company is developing SereneAir, a smart spacer for standard pMDI inhalers that detects whether a medication was taken with correct dose, timing, respiratory flow and inhalation technique. The multimodal sensing includes ultrasound-based flow measurement, optical aerosol detection, acoustic monitoring and IMU orientation sensing. From the collected inhalation data, a respiratory intelligence data platform is created for coaching, therapy monitoring and longitudinal respiratory pattern analysis. The entry market is pediatric asthma therapy. CAELIA Health is being established as a research transfer project at Fraunhofer EMFT in Munich and is funded under EXIST research transfer by the BMWE and ESF Plus. The product is under development and is not CE-marked or commercially available.

Site

Munich

Processes

Smart spacer for pMDI inhalers (SereneAir, in development), Measurement of dose, timing, respiratory flow, inhalation technique and breathing pattern, Multimodal sensing (ultrasound-based flow measurement, optical aerosol detection, acoustic, Feedback/coaching for patients, parents and care teams, Building a respiratory intelligence data platform

Materials

Multimodal Sensing

Industries

MedTech, Digital Health, Inhalation Therapy, Pediatric Asthma and Airway Therapy

1. 01

   Sensor development (ultrasound, optical, acoustic, IMU)

2. 02

   SereneAir hardware development

3. 03

   Respiratory Intelligence software/data platform

4. 04

   Regulatory development along EU MDR / FDA

Sensing & Technology

Locations

History

1. in Gründung

   The CAELIA Health venture team is being established as a research transfer project at Fraunhofer EMFT with EXIST research transfer funding (BMWE / ESF Plus); network: Fraunhofer Venture, Fraunhofer AHEAD, Life Science Factory, Science4Life, TUM Venture Labs Healthcare